Zimmer Biomet CEO David Dvorak Resigns

By MedTech Intelligence Staff

After the abrupt announcement, the search is on for a permanent successor.

David Dvorak, president and CEO of Zimmer Biomet, has resigned. Dvorak served at the company for 16 years, 10 of which he was at the helm as president and CEO. An announcement was made by Zimmer Biomet’s Chairman of the Board Larry Glasscock yesterday: “During David’s 10-year tenure as CEO, Zimmer Biomet has transformed into a truly global leader in musculoskeletal healthcare. Through a combination of organic growth and strategic acquisitions, Zimmer Biomet’s revenue has doubled and the Company has established a leading portfolio of technologies, solutions and personalized services.”

“Serving alongside Zimmer Biomet’s dedicated employees over the past 16 years and leading the Company as CEO for ten of those years has been a privilege and a highlight of my professional career. Our collective efforts grew employment from approximately 3,000 in 2001 to 18,000 today and built a Fortune 500 company. I am particularly proud of what we have accomplished working together with surgeons and clinicians to help millions of patients globally improve their quality of life.” – David Dvorak, former president and CEO of Zimmer Biomet

Senior Vice President and CFO Daniel Florin is taking on an additional role as interim CEO until a permanent replacement has been selected. The company board is retaining an executive search firm to find the right candidate for the position.

Related Articles

About The Author

MedTech Intelligence